Abstract:In the published manuscript, "Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation. Yinggang Hua, Yanling Liu, Long Li and Guoyan Liu, Open Life Sciences. 2023;18(1): 20220078. https://doi.org/10.1515/biol-2022-0078," the authors have found an unintentional error made during preparation of Figure 2. The statement from the authors reads as follows: During our recent review of the experiments described in the article, we identified an issue. Specifically, in Figure 2 of the article, there is an error in the Western blot (WB) images of P-c-Jun and c-Jun. This error occurred during the figure preparation process, where the WB images of P-ERK1/2 and ERK1/2 were mistakenly placed in the positions for P-c-Jun and c-Jun, resulting in repeated images. Figure 1 in this letter highlights the erroneous information. Red box indicates the repeated images of P-c-Jun and c-Jun in Figure 2 of the article. Figure 2 presents the actual WB results for P-c-Jun and c-Jun (MRS2365 agonist and MRS2500 antagonist). (a and b) The WB results for P-c-Jun and c-Jun (MRS2365 agonist and MRS2500 antagonist). Our experimental results indicate that the protein level of P-c-Jun increases after stimulation of SGC-7901 cells with MRS2365 (agonist), suggesting the phosphorylation and activation of c-Jun in the signaling pathway. Based on these accurate and reliable experimental results, we have created a new version of Figure 2 from the original manuscript. The new Figure 2 (here as Figure 3) corrects the WB results for P-c-Jun and c-Jun (MRS2365 agonist and MRS2500 antagonist). The corrected image does not affect the core content and conclusions of the original paper. Corrected version of Figure 2 in the article. The authors admit the error and claim that this is an unintentional error that has nothing to do with academic misconduct and does not influence the conclusion of the publication. The authors apologize to the editor, the staffs of the journal, and the journal readers for the mistake and any inconvenience it caused. # These authors contributed equally to this work. © 2024 the author(s), published by De Gruyter This work is licensed under the Creative Commons Attribution 4.0 International License.

ERRATUM: Mutational landscape of non-functional adrenocortical adenomas

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to “Cd36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Erratum: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Erratum to "Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation"

Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

Correction: Corrigendum: Long Intergenic Non-Coding RNA 271 is Predictive of a Poorer Prognosis of Papillary Thyroid Cancer

Correction To: Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

[Corrigendum] Role of 4‑aminobutyrate Aminotransferase (ABAT) and the Lncrna Co‑expression Network in the Development of Myelodysplastic Syndrome

Corrigendum for “lncrna EPB41L4A-AS1 Regulates Glycolysis and Glutaminolysis by Mediating Nucleolar Translocation of HDAC2” [ebiomedicine 41 (2019) 200–213]

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

ERRATUM: GH modulates hepatic epidermal growth factor signaling in the mouse